Clinical Trials on HER-2 Positive Breast Cancer in Singapore
Total 172 results
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
University of MalayaNational University Hospital, Singapore; Merck Sharp & Dohme LLC; Cancer Research...RecruitingHER2-Negative Breast CancerSingapore, Malaysia
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
National University, SingaporeSingapore General Hospital; National Cancer Centre, SingaporeRecruiting
-
KK Women's and Children's HospitalUnknownBreast Cancer FemaleSingapore
-
National Cancer Centre, SingaporeSingapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaboratorsRecruitingLocally Advanced Breast Cancer | Early-stage Breast CancerSingapore
-
National University Hospital, SingaporeCompletedMetastatic Breast CancerSingapore
-
National University Hospital, SingaporeCompletedEarly Breast CancerSingapore
-
National University Hospital, SingaporeCompletedMetastatic Breast CancerSingapore
-
HE Hong-GuKK Women's and Children's Hospital; Buddy Healthcare Ltd OYUnknownSurgery | Breast Cancer FemaleSingapore
-
National University Hospital, SingaporeCompletedMetastatic Breast CancerSingapore
-
National University, SingaporeNational Cancer Centre, SingaporeUnknownBreast Cancer | Gynecologic Cancer | SurvivorshipSingapore
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
National University of SingaporeNational University Hospital, Singapore; National Cancer Centre, SingaporeCompletedQuality of Life | Oncology | Breast Cancer Survivors | Symptom Management | Mindfulness Based Cognitive TherapySingapore
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
National University Hospital, SingaporeEisai Co., Ltd.UnknownBreast CancerSingapore
-
National Cancer Centre, SingaporeCompleted
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National Cancer Centre, SingaporeTerminated
-
National University Hospital, SingaporeCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
National University Hospital, SingaporeRecruiting
-
National University Hospital, SingaporeEisai Co., Ltd.; Tan Tock Seng HospitalUnknown
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknownBreast CancerSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National Cancer Centre, SingaporeUnknown
-
National University Hospital, SingaporeRecruiting
-
Changi General HospitalCompleted
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), SingaporeActive, not recruiting
-
National University Hospital, SingaporeSingapore Cancer SocietyCompleted
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown